Silence Therapeutics Balance Sheet (2018-2025) | SLN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	63.05M	99.57M	98.53M	99.13M	79.56M	64.94M	106.09M	64.30M	56.80M	37.19M	74.50M	67.06M	143.41M	138.19M	80.50M	121.33M	64.89M	114.20M	102.20M	11.28M
Short-term Investments (Quarter)		0.42M	0.42M	0.41M	0.40M	0.38M	0.33M	19.15M	19.61M	25.65M	0.36M	0.35M	50.36M	50.63M	87.10M	26.00M	71.65M	72.42M	20.16M	73.84M
Cash & Current Investments (Quarter)	63.05M	99.99M	98.94M	99.53M	79.97M	65.32M	106.42M	83.45M	76.41M	62.84M	74.86M	67.41M	193.77M	188.82M	167.60M	147.33M	136.53M	186.62M	122.36M	85.11M
Receivables - Net (Quarter)		0.61M		0.45M	3.45M	3.65M	0.15M	1.07M	2.06M	15.42M	0.59M	0.28M	10.33M	2.13M	0.37M	0.97M	0.04M	0.09M	0.03M
Receivables - Other (Quarter)
Receivables (Quarter)		0.61M		0.45M	3.45M	3.65M	0.15M	1.07M	2.06M	15.42M	0.59M	0.28M	10.33M	2.13M	0.37M	0.97M	0.04M	0.09M	0.03M
Inventory (Quarter)								0.52M	0.48M
Prepaid Assets (Quarter)		5.04M	3.97M	5.81M	8.33M	10.47M	12.19M	9.62M	10.19M	8.47M	14.34M	11.34M	12.87M	15.45M	15.54M	14.66M	16.42M	14.36M	9.26M	11.54M
Current Assets (Quarter)		127.68M	-13.27M	116.38M	103.20M	92.50M	133.71M	113.41M	101.71M	103.00M	110.97M	100.56M	230.53M	222.63M	204.66M	187.37M	169.79M	148.55M	133.63M	118.66M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)		1.83M	2.12M	6.89M	2.55M	2.33M	2.73M	2.58M	2.55M	2.55M	2.44M	2.25M	2.27M	2.13M	2.14M	1.82M	1.69M	1.77M	1.66M	1.58M
Goodwill (Quarter)		10.85M	10.73M	10.23M	10.27M	9.80M	9.38M	9.39M	9.68M	9.73M	9.92M	9.73M	9.76M	9.67M	9.39M	9.39M	9.78M	10.62M	10.61M	10.62M
Intangibles (Quarter)		0.01M	0.00M	0.18M	0.03M	0.03M	0.02M	0.38M	0.38M	0.38M	0.37M	0.35M	0.35M	0.34M	0.34M	0.31M	0.31M	0.32M	0.30M	0.29M
Goodwill & Intangibles (Quarter)		10.86M	10.74M	10.41M	10.30M	9.82M	9.40M	9.77M	10.05M	10.10M	10.30M	10.08M	10.11M	10.01M	10.13M	9.70M	10.09M	10.93M	10.91M	10.91M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)												3.20M	3.25M	2.98M	2.79M	0.36M	3.61M	3.91M	0.40M
Non-Current Assets (Quarter)		13.11M	13.27M	13.29M	13.25M	12.54M	12.47M	12.68M	12.95M	13.01M	13.10M	15.89M	16.04M	15.47M	15.42M	15.27M	15.51M	16.68M	13.16M	12.78M
Assets (Quarter)		140.79M		129.67M	116.45M	105.03M	146.18M	126.09M	114.67M	116.02M	124.06M	116.45M	246.57M	238.10M	220.08M	202.63M	185.30M	165.23M	146.79M	131.44M
Liabilities
Current Liabilities
Accounts Payables (Quarter)		-11.00M	-12.73M	14.54M	-10.31M	-14.73M	-17.45M	14.82M	-16.10M	-15.26M	-15.13M	-15.43M	-13.30M	-18.92M	-18.54M	16.40M	18.81M	14.31M	16.99M	13.36M
Payables (Quarter)		-11.00M	-12.73M	14.54M	-10.31M	-14.73M	-17.45M	14.82M	-16.10M	-15.26M	-15.13M	-15.43M	-13.30M	-18.92M	-18.54M	16.40M	18.81M	14.31M	16.99M	13.36M
Current Leases (Quarter)		-0.25M	-0.18M	0.18M	-0.12M	-0.07M	-0.59M	0.52M	-0.26M	-0.25M	-0.25M	-0.22M	-0.23M	-0.23M	-0.18M	0.12M	0.06M		0.09M	0.09M
Current Deferred Revenue (Quarter)				5.73M				10.40M				6.41M				0.31M	0.39M	0.46M	0.30M	0.17M
Total Current Liabilities (Quarter)		-20.64M	-25.36M	20.45M	-21.10M	-24.63M	-30.56M	25.74M	-21.59M	-24.47M	-22.82M	-22.05M	-17.98M	-22.65M	-21.98M	16.82M	19.26M	14.77M	17.38M	13.61M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)		-87.07M	-79.96M	97.73M	-89.99M	-86.37M	-75.40M	74.46M	-72.64M	-76.00M	-75.76M	-73.12M	-71.30M	-73.44M	-75.30M	51.79M	53.29M	56.31M	55.25M	55.45M
Non-Current Deferred Tax Liability (Quarter)
Operating Leases (Quarter)									0.26M			0.12M							0.10M	0.07M
Total Non-Current Liabilities (Quarter)		-87.07M	-79.96M	97.73M	-89.99M	-86.37M	-75.40M	74.46M	-72.91M	-76.21M	-75.91M	-73.23M	-71.42M	-73.44M	-75.30M
Total Liabilities (Quarter)		107.71M	-22.55M	118.18M	111.10M	111.00M	105.96M	100.20M	94.50M	100.68M	98.73M	95.29M	89.81M	96.09M	97.28M	68.61M	72.56M	71.08M	72.73M	69.14M
Shareholder's Equity
Common Equity (Quarter)		33.08M	22.55M	11.49M	5.35M	-5.97M	40.23M	25.89M	20.17M	15.34M	25.33M	21.16M	156.76M	142.53M	126.70M	134.02M	112.74M	94.16M	74.06M	62.30M
Shareholder's Equity (Quarter)				11.49M				25.89M		15.34M	25.33M	21.16M	156.76M	142.53M	126.70M	134.02M	112.74M	94.16M	74.06M	62.30M
Liabilities and Shareholders Equity (Quarter)		140.79M		129.67M	116.45M	105.03M	146.18M	126.09M	114.67M	116.02M	124.06M	119.45M	246.57M	238.10M	220.08M	202.63M	185.30M	165.23M	146.79M	131.44M
Retained Earnings (Quarter)		-284.69M	-294.40M	-300.56M	-309.49M	-305.46M	-294.22M	-308.79M	-331.12M	-353.84M	-368.10M	-378.07M	-387.79M	-404.10M	-450.40M	-474.04M	-502.50M	-529.84M	-550.80M	-2.98M

Research Tools

Silence Therapeutics Balance Sheet (2018-2025) | SLN

Create an account

Sign In

Reset Password